In BC cells, PARP6 regulates the activity of cycle checkpoint kinase 1 (Chk1), a key downstream factor in the ataxia telangiectasia and Rad3-related (ATR) pathway (49), via ADP-ribosylation, thereby maintaining centrosome integrity and ultimately promoting the development of BC (50, 51). This evidence concerns the gene PARP6 and breast cancer.